Orlistat

Weight Management

Orlistat is primarily used to help people lose weight and prevent the regain of weight they have already lost. It is intended for use by adults who are overweight or obese.

Target Population

Healthcare providers typically recommend orlistat for individuals with a body mass index (BMI) of 30 or higher. It may also be used for people with a BMI of 27 or higher who have other health risk factors, such as:

• High blood pressure (hypertension)
• Diabetes
• High cholesterol
• Heart disease

Lifestyle Integration

This medication is not a standalone treatment. It is designed to be used as part of a comprehensive weight management plan that includes:

• A reduced-calorie diet
• A low-fat diet
• Regular physical activity or exercise

Orlistat is available in two forms: a prescription-strength version for clinical obesity management and a lower-dose over-the-counter version for overweight adults.

Mechanism of Action

Orlistat works by interfering with the way the body processes dietary fat. It belongs to a group of medicines called lipase inhibitors, which target specific enzymes in the digestive tract.

Inhibiting Lipase Enzymes

Normally, enzymes called lipases found in the stomach and small intestine break down the fats you eat into smaller components. This process allows the body to absorb those fats for energy or storage. When orlistat is taken with a meal, it binds to these lipase enzymes and prevents them from doing their job.

As a result, a portion of the fat consumed remains undigested. Because the body cannot absorb undigested fat, it simply passes through the digestive system and is eliminated from the body through bowel movements.

Key Features

• Local Action: Orlistat acts primarily within the gut and is not significantly absorbed into the bloodstream.
• Selective Blocking: The medication specifically targets fat; it does not block the absorption of calories from sugar, protein, or other non-fat food sources.
• Elimination: The fat that is not absorbed is typically removed from the body within 24 to 48 hours after consumption.

Common Side Effects

The most frequent side effects of orlistat are related to its effect on fat absorption in the digestive tract. These symptoms are often more noticeable after eating meals with a high fat content. Common symptoms include:

• Oily spotting in undergarments
• Gas with oily discharge
• Urgent or frequent bowel movements
• Fatty or oily stools that may appear orange or brown
• Inability to control bowel movements
• Stomach pain or discomfort
• Nausea
• Rectal pain

Serious Side Effects

While less common, some side effects require immediate medical attention. Contact a healthcare provider if you experience:

• Signs of liver problems: Yellowing of the eyes or skin (jaundice), dark-colored urine, light-colored stools, severe itching, loss of appetite, or pain in the upper right side of the stomach.
• Signs of kidney stones: Severe pain in the back or side, blood in the urine, or painful urination.
• Allergic reactions: Hives, skin rash, itching, or difficulty breathing or swallowing.
• Severe or persistent stomach pain.

Serious Liver Injury

Rare cases of severe liver injury have been reported in people taking orlistat. Medical attention is necessary if symptoms of liver dysfunction occur, such as yellowing of the skin or eyes (jaundice), dark-colored urine, itching, loss of appetite, or pain in the upper right side of the stomach area.

Malabsorption and Pregnancy

Orlistat is not recommended for individuals with chronic malabsorption syndrome or cholestasis (a condition where bile flow from the liver is blocked). It should also not be used during pregnancy, as weight loss offers no potential benefit to a pregnant woman and may result in fetal harm.

Kidney and Gallbladder Concerns

Some people taking orlistat may develop increased levels of oxalate in their urine, which can lead to calcium oxalate kidney stones or kidney damage. Those with a history of kidney stones or existing kidney disease should use this medication with caution. Additionally, orlistat has been associated with reports of gallstones and pancreatitis.

Nutritional Deficiencies

Because orlistat prevents the absorption of some fat, it also interferes with the absorption of fat-soluble vitamins (A, D, E, and K) and beta-carotene. To prevent nutritional deficiencies, a daily multivitamin is typically recommended, taken at least two hours before or after taking orlistat, such as at bedtime.

Other Precautions

• Diabetes: Weight loss may improve blood sugar control, potentially requiring adjustments to diabetes medications like insulin or oral glucose-lowering drugs.
• Thyroid Disease: Orlistat may affect the absorption of levothyroxine. Thyroid hormone levels should be monitored closely if these medications are used together.
• Eating Disorders: This medication is not recommended for individuals with a history of anorexia nervosa or bulimia.
• Cyclosporine: Orlistat can significantly reduce the absorption of cyclosporine; these drugs should be taken several hours apart with frequent monitoring of cyclosporine levels.

Pregnancy

Orlistat should not be used during pregnancy. Medical experts note that weight loss offers no potential benefit to a pregnant individual and may result in fetal harm. Current clinical guidelines generally recommend a minimum weight gain, rather than weight loss, for all pregnant individuals, including those who are already overweight or obese.

If you become pregnant while taking orlistat, you should stop taking the medication immediately and contact your healthcare provider.

Breastfeeding

It is not currently known whether orlistat passes into human breast milk. Because the safety of this medication for nursing infants has not been established, it is generally not recommended for use while breastfeeding. Individuals who are nursing should consult with a healthcare professional to discuss whether to discontinue the drug or discontinue nursing.

Dosage Forms

Orlistat is provided in the following form:

• Oral Capsule: This medication is taken by mouth, typically with each main meal that contains fat.

The medication is available as a prescription product and as an over-the-counter option. Both versions consist of the same active ingredient and are intended for use alongside a reduced-calorie, low-fat diet and exercise program.

FDA Approval History

The U.S. Food and Drug Administration (FDA) first approved orlistat as a prescription medication in 1999. In 2007, a lower-dose version was approved for over-the-counter (OTC) use, making it the first non-prescription weight-loss drug to receive FDA approval.

Approved Indications

Orlistat is indicated for weight loss and weight maintenance when used alongside a reduced-calorie, low-fat diet. The regulatory status differs by strength:

• Prescription strength: Approved for use in obese adults and for certain overweight patients who also have risk factors such as high blood pressure, diabetes, or high cholesterol. It is also approved for use in pediatric patients aged 12 to 16 years.
• Over-the-counter strength: Approved for use in overweight adults aged 18 years and older.

Safety Communications

In 2010, the FDA completed a safety review regarding rare but serious reports of liver injury in patients using orlistat. While a direct cause-and-effect relationship was not definitively established, the FDA required that the drug labels be updated to include information about these rare events. Patients are advised to watch for signs of liver dysfunction, such as yellowing of the skin or eyes (jaundice) and dark urine.

Regulatory Classification

Orlistat is not classified as a controlled substance. Unlike some other weight-loss medications, it does not act as a stimulant on the central nervous system.

How Orlistat Works

Orlistat belongs to a class of medications known as lipase inhibitors. Unlike many other weight-loss drugs that suppress appetite, orlistat works in the digestive system to block the enzyme that breaks down fats. This prevents approximately 25% to 30% of the fat consumed in a meal from being absorbed by the body. The unabsorbed fat is then eliminated through bowel movements.

Usage and Eligibility

Orlistat is intended for use by adults who are overweight or obese. It is generally recommended for:

• Adults with a body mass index (BMI) of 30 or higher.
• Adults with a BMI of 27 or higher who also have weight-related health conditions such as high blood pressure, diabetes, or high cholesterol.
• Overweight adults (BMI of 25 or higher) when using the over-the-counter version of the medication.

The medication is only effective when taken with a meal that contains fat. If a meal is skipped or contains no fat, the dose of orlistat should also be skipped.

Effectiveness and Dietary Requirements

Weight loss typically begins within two weeks of starting treatment and can continue for six to twelve months. To achieve the best results and minimize digestive side effects, users should follow a physician-approved exercise program and a reduced-calorie diet. The daily intake of fat should be distributed evenly across three main meals and should not exceed 30% of total daily calories.

Nutritional Considerations

Because orlistat blocks the absorption of some fats, it can also interfere with the body's ability to absorb fat-soluble vitamins, including vitamins A, D, E, and K, as well as beta-carotene. To prevent nutritional deficiencies, healthcare providers usually recommend taking a daily multivitamin. This supplement should be taken at least two hours before or after taking orlistat, such as at bedtime, to ensure proper absorption.